Home/Investors/TF Capital TF Capital
Biotech Investor · 17 portfolio companies
Portfolio Companies
| Company | Stage | Valuation | Focus |
|---|
| Impact Therapeutics | phase-3 | — | Oncology |
| ImmuneOnco Biopharma | phase-2 | — | Oncology, Immunology |
| Evive Biotech | phase-2 | — | Metabolic |
| Drug Farm | preclinical | — | Infectious Disease, Oncology |
| MabPlex | platform | — | Oncology, Immunology |
| Biomics Biopharma | preclinical | — | Oncology, Gene Therapy |
| Triastek | phase-2 | — | Gastrointestinal Diseases, Central Nervous System Diseases |
| Hepagene Therapeutics | phase-2 | — | Infectious Disease, Metabolic |
| HighTide Therapeutics | phase-3 | — | Metabolic |
| Hexaell Biotech | phase-2 | — | Regenerative Medicine, Oncology |
| Immunotech Biopharm | phase-1 | — | Oncology, Immunology |
| Joinstar Biomedical Technology | phase-1 | — | Oncology |
| Bliss Biopharmaceutical | phase-1 | — | Oncology |
| Lupeng Pharmaceutical | phase-2 | — | Neuroscience |
| iSIA Bio-technology | preclinical | — | Oncology |
| CorreGene | preclinical | — | Rare Disease, Gene Therapy |
| Ascentawits Pharmaceuticals | preclinical | — | Oncology, Immunology |